Current location:Earth Enigma news portal > sport
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Earth Enigma news portal2024-05-21 19:45:08【sport】0People have gathered around
IntroductionWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the b
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Address of this article:http://eritrea.claboston.org/article-73a499507.html
Very good!(9)
Related articles
- Lynn Williams breaks NWSL goal
- Sculpture erected to create awareness on neurological disease in Brazil
- Highlights of semifinals at BWF Korea Open Badminton Championships 2022
- Alibaba returns to simple and agile structure
- Not so Cool Britannia! Noel Gallagher gives damning verdict on Keir Starmer
- China launches new land
- Apps simplify expense steps for foreign users
- China criticizes Fitch's sovereign rating downgrade
- Ohio judge to rule Monday on whether the state’s abortion ban stands
- People enjoy Labor Day holiday across China
Popular articles
Recommended
Fresh heartache for cancer
People enjoy Labor Day holiday across China
Xi Sends Congratulatory Letter to Forum on Civilization and Sinology
Highlights of Beijing 2022 Paralymic Torch Relay and Flame Lighting Ceremony
Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
Cold snap sweeps eastern U.S.
Macron, Le Pen lead 1st round of French presidential election
CPC Leadership Reviews Guidelines on Policies Supporting Construction of Xiong'an
Links
- People Celebrate Tibetan New Year in China's Tibet
- China Focus: China Works to Meet Demand for Elderly Nursing Care Beds
- Various Events Held Across China to Celebrate Upcoming Lantern Festival
- China Steps up Personality Rights Protection on Internet
- Winter Sports Take Root in Dual
- National Ear Care Day Marked Across China
- Children's Health Continues to Improve
- Beijing Winter Olympic Medals Pass Acceptance Test
- China Focus: China to Deliver Improved Community Services to Both Urban, Rural Dwellers
- China Has Nearly 300 Million Students in 2021